XTNT Xtant Medical Holdings, Inc.

$0.43 -1.13%

Healthcare · Surgical & Medical Instruments & Apparatus

Xtant Medical Holdings, Inc. (XTNT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $60 million. Shares last traded at $0.43, 54.7% below their 52-week high. Over the past year the stock is down 33.8%. XTNT trades at a price-to-earnings ratio of 12.13, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 3.7%, above the peer median of -7.6%. Revenue grew 14.2% year over year.

Market Cap

$60M

Shares Out

140.3M

EPS (TTM)

$0.03

P/E Ratio

14.34

P/S Ratio

0.45

P/B Ratio

1.24

Dividend / Share

—

Dividend Yield

—

52-Week High

$0.95

52-Week Low

$0.43

Volume

152

Avg Vol (3m)

2,216.571

Performance

-1.80%

-4.42%

-26.80%

-38.85%

YTD

-42.43%

-33.83%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

33.60

SMA (50)

$0.49

SMA (200)

$0.62

Price vs SMA50

-11.93%

Price vs SMA200

-30.54%

ATR (14)

$0.01

Financials

Revenue

$134M

Net Income

$5M

Gross Margin

62.9%

Operating Margin

5.4%

Net Margin

3.7%

Return on Equity

10.2%

Return on Assets

6.4%

Current Ratio

3.34

Debt / Equity

0.17

Revenue Growth (YoY)

+14.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.02	2026-05-13
FY 2025	$0.03	2026-03-31
Q3 2025	$0.03	2025-11-10
Q2 2025	$0.02	2025-08-12
Q1 2026	$0.00	2026-05-13
FY 2025	$-0.12	2026-03-31

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

XTNT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers

12.13 / 28.73 med

-58% discount

P/S vs peers

0.45 / 2.52 med

-82% discount

Net margin vs peers

3.7% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.